Inventor
VAN DER VEKEN LOUIS JOZEF ELISABETH
BE14 patents
⚠️ This page may combine multiple inventors who share the name “VAN DER VEKEN LOUIS JOZEF ELISABETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
12 patentsUS7816360B2Oct 19, 2010
MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
JANSSEN PHARMACEUTICA NV9 citations83
US7504400B2Mar 17, 2009
MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
JANSSEN PHARMACEUTICA NV8 citations83
US7968601B2Jun 28, 2011
Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV15 citations80
US7687644B2Mar 30, 2010
Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV12 citations79
US8344181B2Jan 1, 2013
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV6 citations71
US8354402B2Jan 15, 2013
Polyarylcarboxamides useful as lipid lowering agents
JANSSEN PHARMACEUTICA NV0 citations51
US7528154B2May 5, 2009
Polyarylcarboxamides useful as lipid lowering agents
JANSSEN PHARMACEUTICA NV0 citations51
US9630921B2Apr 25, 2017
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9422284B2Aug 23, 2016
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9150512B2Oct 6, 2015
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9776965B2Oct 3, 2017
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations47
US9302987B2Apr 5, 2016
Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
JANSSEN PHARMACEUTICA NV0 citations47